Fetal Alcohol Syndrome Clinical Trial
— ALCOBRAINOfficial title:
In Utero Alcoholic Exposure: PlGF, Biomarker of Fetal Brain Lesions
This study aims to validate that PLGF is a biomarker of cerebral lesions and therefore of secondary developmental disorders and disabilities that will be best diagnosed at 2 and 6 years of age.
Status | Recruiting |
Enrollment | 60 |
Est. completion date | January 27, 2025 |
Est. primary completion date | January 27, 2019 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: Mother: - Pregnant woman (monofetal or twin pregnancy, whatever the parity) - Age> or = to 18 years - Person affiliated to a social security system - Person who read and understood the information form and signed the consent form - Alcohol exposure group Chronic consumption of at least 30 g of alcohol per week or acute consumption of "binge drinking" type during pregnancy (knowing that a unit of 10 g of pure alcohol corresponds to 25 cl of beer 4 ° 5, 10 cl of wine at 12 °, 3 cl of whiskey, 7 cl of Porto ...) - Control group No alcohol consumption during pregnancy - Child Informed parents and written consent signed by the father and mother for the child's participation in this research (unless one of the parents does not have parental authority) Exclusion Criteria: - Female under 18 - Pregnant woman with clinical suspicion of pre-eclampsia and / or HELLP syndrome - Person deprived of liberty by an administrative or judicial decision or protected major subject (under tutorship or curatorship) - Patient participating in another interventional trial or who participated in another interventional trial during pregnancy |
Country | Name | City | State |
---|---|---|---|
France | UH ROUEN | Rouen |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Rouen |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | PLGF concentrations in the umbilical cord | Compare concentrations between 2 groups of mother / child pairs: in utero exposure to alcohol versus control. | Through inclusion completion and samples analyses, an average of 4 months after the end of inclusions | |
Primary | PLGF concentrations in placenta | Compare concentrations between 2 groups of mother / child pairs: in utero exposure to alcohol versus control. | Through inclusion completion and samples analyses, an average of 4 months after the end of inclusions | |
Secondary | Assessment of the concentration of PLGF in maternal blood | Blood sample | Through inclusion completion and samples analyses, an average of 4 months after the end of inclusions | |
Secondary | Studies of metabolomic profile on blood sample | blood sample metabolomic profile | Through inclusion completion and samples analyses, an average of 4 months after the end of inclusions | |
Secondary | Studies of metabolomic profile on placenta | placenta metabolomic profile | Through inclusion completion and samples analyses, an average of 4 months after the end of inclusions | |
Secondary | Neurological clinical evaluation | Clinical exam | The day of birth | |
Secondary | Follow-up at 2 years in pediatric consultation for evaluation of neuro-development | ASQ: Ages & Stages Questionnaires. This questionnaire screens and assesses the developmental performance of children in the areas of communication, gross motor skills, fine motor skills, problem solving, and personal-social skills. It is used to identify children that would benefit from in-depth evaluation for developmental delays. | 2 years | |
Secondary | Follow-up at 6 years in consultation for assessment of neurodevelopment with | parental ASQ: Ages & Stages Questionnaire screens and assesses the developmental performance of children in the areas of communication, gross motor skills, fine motor skills, problem solving, and personal-social skills. It is used to identify children that would benefit from in-depth evaluation for developmental delays. | 6 years | |
Secondary | Follow-up at 6 years in consultation for assessment of neuropsychological assessment: Wechsler Preschool and Primary Scale of Intelligence: WPPSI IV | WPPSI - IV: The Wechsler Preschool and Primary Scale of Intelligence consist of 14 subtests. They are designated as one of three types: core, supplemental, or optional. The core subtests are required for the computation of the Verbal, Performance, and Full Scale IQ. The supplemental subtests provide additional information about cognitive abilities or can be used as replacement for inappropriate subtests. The optional subtests provide additional information about cognitive functioning but cannot be used as replacements for core subtests. Quotient and Composite scores have a mean of 100 and a standard deviation of 15. Subtest scaled scores have a mean of 10 and a standard deviation of 3.elow 70 is Extremely Low, 70-79 is Borderline, 80-89 is Low Average, 90-109 is Average, 110-119 is High Average, 120-129 is Superior, 130+ is Very Superior. | 6 years | |
Secondary | Follow-up at 6 years in consultation for assessment of neuropsychological assessment: Developmental NEuroPSYchological Assessment | NEPSY -NEuroPSYchological Assessment. The six functional domains are made up of 32 subtests and four delayed tasks. These domains are theoretically, not statistically, derived. The subtests were designed to assess cognitive abilities related to disorders that are typically diagnosed in childhood and that are required for success in an academic environment. These tests supposedly help detect any underlying deficiencies that may impede a child's learning | 6 years | |
Secondary | Follow-up at 6 years in consultation for assessment of neuropsychological assessment: Conners' scale | Conners scale is assessing for attention deficit hyperactivity disorder (ADHD) | 6 years | |
Secondary | Follow-up at 6 years in consultation for assessment of neuropsychological assessment: SCQ Social Communication Questionnaire | SCQ: The Social Communication is a 40 item, parent report screening measure that taps the symptomatology associaed with autism Spectrum disorder (ASD). The items are administered in a yes/non response format. | 6 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06163651 -
Evaluating a One-Year Version of the Parent-Child Assistance Program
|
N/A | |
Active, not recruiting |
NCT00996528 -
Neighborhood Alcohol & HIV Prevention in South African Townships (Philani)
|
Phase 3 | |
Completed |
NCT00164229 -
Fetal Alcohol Syndrome: Socio-Cognitive Habilitation
|
Phase 1/Phase 2 | |
Completed |
NCT00164554 -
Fetal Alcohol Syndrome/ARND Research Consortion
|
Phase 1/Phase 2 | |
Recruiting |
NCT05534568 -
The Oklahoma Parent-Child Assistance Program
|
N/A | |
Recruiting |
NCT05385328 -
Multisensorial Analysis of Human Activity for Diagnosis and Early Detection of Functional Limitations
|
||
Completed |
NCT01911299 -
Choline Supplementation in Children With Fetal Alcohol Spectrum Disorders
|
Phase 2 | |
Terminated |
NCT00747630 -
Evaluating the Efficacy of a Video Based Intervention to Educate Teen Moms About Fetal Alcohol Syndrome (FAS)
|
Phase 0 | |
Recruiting |
NCT04332172 -
Scaling Up: A Multi-Site Trial of e-SBI for Alcohol Use in Pregnancy
|
N/A | |
Completed |
NCT00696085 -
Fetal Alcohol Damage Prevention Study
|
N/A | |
Recruiting |
NCT00418262 -
Open-Label Study of the Long Term Tolerability and Safety of Atomoxetine in Children With FASD and ADD/ADHD
|
Phase 3 | |
Completed |
NCT01149538 -
Postnatal Choline Supplementation in Children With Prenatal Alcohol Exposure
|
Phase 1/Phase 2 | |
Completed |
NCT00164346 -
Neurocognitive Habilitation for Children With Fetal Alcohol Syndrome (FAS)/Alcohol-Related Neurodevelopmental Disorder (ARND)
|
Phase 1/Phase 2 | |
Completed |
NCT01994603 -
Expansion to Interdisciplinary HIV Prevention in Women
|
N/A | |
Completed |
NCT00417794 -
Assess the Effectiveness of Atomoxetine in Children With Fetal Alcohol Syndrome and ADD/ADHD
|
Phase 1 | |
Completed |
NCT02600624 -
Prenatal Alcohol Biomarker Study in Uruguay
|
||
Completed |
NCT00244062 -
Healthy Moms Alcohol Intervention
|
N/A | |
Recruiting |
NCT04395196 -
RCT of Prenatal Choline Supplementation During Pregnancy to Mitigate Adverse Effects of Prenatal Alcohol Exposure
|
Phase 2 |